Profile data is unavailable for this security.
About the company
Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.
- Revenue in USD (TTM)18.67m
- Net income in USD-1.99m
- Incorporated2019
- Employees96.00
- LocationBon Natural Life LtdC601, Gazelle Valley, No.69Jinye Rd., Xi'an-Tech ZoneXI'AN 710076ChinaCHN
- Phone+86 2 988346301
- Websitehttps://www.bnlus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine Biopharma Inc | 37.32m | -5.99m | 5.59m | 52.00 | -- | 0.2147 | -- | 0.1499 | -2.03 | -2.03 | 10.74 | 5.31 | 1.21 | 2.09 | 10.12 | 717,764.30 | -19.47 | -68.65 | -23.80 | -89.02 | 33.01 | 32.79 | -16.06 | -81.12 | 2.09 | -209.95 | 0.00 | -- | 44.75 | 340.11 | -13.94 | -- | 370.33 | -- |
| Cuprina Holdings (Cayman) Ltd | 23.75k | -2.22m | 7.12m | 14.00 | -- | 1.18 | -- | 299.79 | -0.1219 | -0.1219 | 0.0013 | 0.2801 | 0.0049 | 13.39 | 0.7976 | 1,696.23 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Nutraproducts Inc | 0.00 | -821.94k | 7.85m | 0.00 | -- | 1.31 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Gelteq Ltd | 116.50k | -4.67m | 8.03m | 7.00 | -- | 0.7223 | -- | 68.92 | -0.4952 | -0.4952 | 0.0123 | 1.04 | 0.0078 | -- | 0.5155 | 16,643.07 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| cbdMD Inc | 19.09m | -3.71m | 8.09m | 42.00 | -- | 0.8621 | -- | 0.4238 | -2.23 | -2.23 | 3.11 | 0.8945 | 1.64 | 2.95 | 15.97 | -- | -20.06 | -48.27 | -41.11 | -54.99 | 60.59 | 63.95 | -12.25 | -85.60 | 1.87 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Nexgel Inc | 11.67m | -2.88m | 8.79m | 19.00 | -- | 1.70 | -- | 0.7539 | -0.3796 | -0.3796 | 1.53 | 0.6369 | 1.05 | 3.79 | 13.46 | 613,947.40 | -25.14 | -39.08 | -36.83 | -49.79 | 38.30 | 19.60 | -23.91 | -105.40 | 1.08 | -51.36 | 0.1439 | -- | 112.47 | 64.69 | -3.93 | -- | -- | -- |
| Integrated Biopharma Inc | 52.09m | -206.00k | 9.32m | 153.00 | -- | 0.4717 | 81.79 | 0.179 | -0.007 | -0.007 | 1.67 | 0.6365 | 2.12 | 4.94 | 13.32 | 340,464.10 | -0.8373 | 9.98 | -1.03 | 13.68 | 7.81 | 10.74 | -0.3955 | 4.58 | 2.67 | -- | 0.0069 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 9.99m | 96.00 | 18.40 | 0.2288 | -- | 0.5352 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Biofrontera Inc | 37.17m | -17.57m | 10.42m | 92.00 | -- | -- | -- | 0.2805 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 10.53m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 10.74m | 233.00 | 0.0734 | 0.0011 | 2.78 | 0.1518 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 11.36m | 11.00 | -- | 1.14 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| CV Sciences Inc | 14.37m | -1.48m | 12.65m | 47.00 | -- | 8.22 | -- | 0.8802 | -0.008 | -0.008 | 0.078 | 0.0084 | 1.87 | 1.67 | 34.74 | 305,659.60 | -19.21 | -44.92 | -66.32 | -105.32 | 47.04 | 42.89 | -10.29 | -49.08 | 0.2125 | -2.02 | 0.3829 | -- | -1.87 | -21.80 | -177.18 | -- | -56.43 | -- |
Data as of Mar 03 2026. Currency figures normalised to Bon Natural Life Ltd's reporting currency: US Dollar USD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Securities LLCas of 31 Dec 2025 | 700.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 1.00 | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
